세계의 구강건조증 치료 시장 : 제품, 약제 유형, 유통 채널별 예측(2025-2030년)

The Xerostomia Therapeutics Market was valued at USD 2.24 billion in 2023, expected to reach USD 2.35 billion in 2024, and is projected to grow at a CAGR of 4.60%, to USD 3.07 billion by 2030.

The xerostomia therapeutics market focuses on addressing dry mouth conditions resulting from reduced or absent saliva production, often due to medication side effects, autoimmune diseases like Sjogren's syndrome, or treatments like chemotherapy and radiation. The necessity of xerostomia therapeutics is underscored by its impact on patients' quality of life, leading to difficulties in chewing, swallowing, speaking, and increased dental health issues. Key applications include pharmaceutical agents such as saliva stimulants, saliva substitutes, and systemic sialogogues, with end-use contexts covering hospitals, dental clinics, and homecare settings. Market growth is influenced by factors like rising incidences of Sjogren's syndrome and the aging population, which increases the prevalence of conditions contributing to xerostomia. There is a potential opportunity in the development of novel therapeutics with fewer side effects and improved efficacy, particularly for patients undergoing radiotherapy or those suffering from autoimmune disorders.

However, the market faces limitations due to the often temporary relief offered by existing treatments, high costs associated with innovative therapies, and limited awareness of xerostomia's impact among the general population. Challenges also include stringent regulatory pathways for new drug approvals and the need for extensive clinical trials. For innovation, research could focus on formulating long-acting biologics, exploring gene therapy options, and enhancing delivery systems for existing solutions. Additionally, leveraging digital health technologies to create better patient education and monitoring tools could substantially improve patient outcomes and adherence to treatment plans. The market is characterized by a moderate to high level of competition, with several established players and emerging startups driving research and development. Companies that prioritize strategic collaborations for drug development, invest in personalized medicine, and focus on expanding geographical reach into emerging markets may capture significant market shares and achieve sustained growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Xerostomia Therapeutics Market

The Xerostomia Therapeutics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing incidences of xerostomia in the aging population
  • Growing awareness about xerostomia-related products
  • Ongoing research and development for the development of efficient products for xerostomia
• Market Restraints
  • High cost of medications and medical treatments associated with xerostomia therapies
• Market Opportunities
  • Improvements in xerostomia drugs and treatments
  • Clinical trials to study the efficacy of xerostomia drugs
• Market Challenges
  • Strict regulations pertaining to marketing and selling xerostomia-related products

Porter's Five Forces: A Strategic Tool for Navigating the Xerostomia Therapeutics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Xerostomia Therapeutics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Xerostomia Therapeutics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Xerostomia Therapeutics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Xerostomia Therapeutics Market

A detailed market share analysis in the Xerostomia Therapeutics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Xerostomia Therapeutics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Xerostomia Therapeutics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Xerostomia Therapeutics Market

A strategic analysis of the Xerostomia Therapeutics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Xerostomia Therapeutics Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Advanz Pharma Corp., Bausch Health Companies Inc., Bio Cosmetics Laboratories, S.L., Biodexa Pharmaceuticals PLC, CCMed Ltd., Chattem, Inc. by Sanofi S.A., Cipla Ltd., Colgate-Palmolive Company, Cyclacel Pharmaceuticals, Inc., Forward Science, Fresenius Kabi AG, Fresenius SE & Co. KGaA, GlaxoSmithKline PLC, Hikma Pharmaceuticals PLC, ICPA Health Products Ltd, Lupin Limited, Mission Pharmacal Company, Parnell Pharmaceuticals Inc., Perrigo Company plc, Pharmascience Inc., Quest Products Inc., Saliwell Ltd, Sun Pharmaceutical Industries Ltd., and Synedgen Inc..

Market Segmentation & Coverage

This research report categorizes the Xerostomia Therapeutics Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Offering, market is studied across OTC and Prescription.
• Based on Drug Type, market is studied across Dentifrices, Salivary Stimulants, and Salivary Substitutes.
• Based on Distribution Channel, market is studied across Hospital and Pharmacies. The Pharmacies is further studied across Offline and Online.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing incidences of xerostomia in the aging population
    • 5.1.1.2. Growing awareness about xerostomia-related products
    • 5.1.1.3. Ongoing research and development for the development of efficient products for xerostomia
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of medications and medical treatments associated with xerostomia therapies
  • 5.1.3. Opportunities
    • 5.1.3.1. Improvements in xerostomia drugs and treatments
    • 5.1.3.2. Clinical trials to study the efficacy of xerostomia drugs
  • 5.1.4. Challenges
    • 5.1.4.1. Strict regulations pertaining to marketing and selling xerostomia-related products
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Xerostomia Therapeutics Market, by Offering

• 6.1. Introduction
• 6.2. OTC
• 6.3. Prescription

7. Xerostomia Therapeutics Market, by Drug Type

• 7.1. Introduction
• 7.2. Dentifrices
• 7.3. Salivary Stimulants
• 7.4. Salivary Substitutes

8. Xerostomia Therapeutics Market, by Distribution Channel

• 8.1. Introduction
• 8.2. Hospital
• 8.3. Pharmacies
  • 8.3.1. Offline
  • 8.3.2. Online

9. Americas Xerostomia Therapeutics Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Xerostomia Therapeutics Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Xerostomia Therapeutics Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. 3M Company
• 2. Advanz Pharma Corp.
• 3. Bausch Health Companies Inc.
• 4. Bio Cosmetics Laboratories, S.L.
• 5. Biodexa Pharmaceuticals PLC
• 6. CCMed Ltd.
• 7. Chattem, Inc. by Sanofi S.A.
• 8. Cipla Ltd.
• 9. Colgate-Palmolive Company
• 10. Cyclacel Pharmaceuticals, Inc.
• 11. Forward Science
• 12. Fresenius Kabi AG
• 13. Fresenius SE & Co. KGaA
• 14. GlaxoSmithKline PLC
• 15. Hikma Pharmaceuticals PLC
• 16. ICPA Health Products Ltd
• 17. Lupin Limited
• 18. Mission Pharmacal Company
• 19. Parnell Pharmaceuticals Inc.
• 20. Perrigo Company plc
• 21. Pharmascience Inc.
• 22. Quest Products Inc.
• 23. Saliwell Ltd
• 24. Sun Pharmaceutical Industries Ltd.
• 25. Synedgen Inc.